Stop diabetes with AI-driven LDcoder

Scientific breakthrough: the discovery of blood biomarker for Type 2 diabetes early risk detection.

LDcoder® was developed based on large international clinical studies performed on more than 8000 individuals followed for up to 20 years from 8 counties. It is a fruitful collaboration between 22 institutes, hospitals and universities from Sweden, Finland, Germany, US, UK, France, Switzerland, Italy, Denmark and China. The study was led by Dr. Yang De Marinis, Associate Professor at Lund University and Professor at Shandong University, who is also the Founder and CEO of Lundoch Diagnostics.

The breakthrough discovery was published in the prestigious scientific journal Nature Communications, entitled " Elevated circulating follistatin associates with an increased risk of type 2 diabetes". This large international study revealed that higher levels of the protein follistatin predict diabetes many years before diagnosis, regardless of other known risk factors, such as age, body mass index (BMI), fasting blood glucose levels, diet or physical activity.